Stable heterodimers from remodeling the domain interface of a homodimer using a phage display library.

Structure-guided phage display was used to select for combinations of interface residues for antibody C(H)3 domains that promote the formation of stable heterodimers. A C(H)3 "knob" mutant was made by replacement of a small residue, threonine, with a larger one, tryptophan: T366W. A library of C(H)3 "hole" mutants was then created by randomizing residues 366, 368 and 407, which are in proximity to the knob on the partner C(H)3 domain. The C(H)3 knob mutant was fused to a peptide flag and the C(H)3 hole library was fused to M13 gene III. Phage displaying stable C(H)3 heterodimers were recovered by panning using an anti-flag antibody. Phage-selected C(H)3 heterodimers differed in sequence from the previously designed heterodimer T366W-Y407'A, and most clones tested were more stable to guanidine hydrochloride denaturation. The thermal stability of individual C(H)3 domains secreted from Escherichia coli was analyzed by differential scanning calorimetry. One heterodimer, T366W-T366'S:L368'A:Y407'V, had a t(m) of 69.4 degrees C, which is 4.0 deg.C higher than that for the designed heterodimer and 11.0 deg.C lower than that for the wild-type homodimer. The phage-selected C(H)3 mutant maintained the preference for forming heterodimers over homodimers as judged by near-quantitative formation of an antibody/immunoadhesin hybrid in a cotransfection assay. Phage optimization provides a complementary and more comprehensive strategy to rational design for engineering homodimers for heterodimerization.

[1]  G. P. Smith,et al.  Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. , 1985, Science.

[2]  Development of humanized bispecific antibodies reactive with cytotoxic lymphocytes and tumor cells overexpressing the HER2 protooncogene , 1992, The Journal of experimental medicine.

[3]  S. Bass,et al.  Selecting high-affinity binding proteins by monovalent phage display. , 1991, Biochemistry.

[4]  S. Miller.  Protein-protein recognition and the association of immunoglobulin constant domains. , 1990, Journal of molecular biology.

[5]  N. Scrutton,et al.  Engineering surface charge. 2. A method for purifying heterodimers of Escherichia coli glutathione reductase. , 1992, Biochemistry.

[6]  Phage display of peptide libraries on protein scaffolds. , 1998, Methods in molecular biology.

[7]  G. Winter,et al.  In vitro assembly of repertoires of antibody chains on the surface of phage by renaturation. , 1994, Journal of molecular biology.

[8]  L. Presta,et al.  Engineering a humanized bispecific F(ab')2 fragment for improved binding to T cells. , 1992, International journal of cancer. Supplement = Journal international du cancer. Supplement.

[9]  S. Marsters,et al.  A humanized, bispecific immunoadhesin-antibody that retargets CD3+ effectors to kill HIV-1-infected cells. , 1994, Journal of hematotherapy.

[10]  Brad Snedecor,et al.  High Level Escherichia coli Expression and Production of a Bivalent Humanized Antibody Fragment , 1992, Bio/Technology.

[11]  B. Quimby,et al.  Heterodimer formation and activity in the human enzyme galactose-1-phosphate uridylyltransferase. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[12]  H. K. Schachman,et al.  Shared active sites in oligomeric enzymes: model studies with defective mutants of aspartate transcarbamoylase produced by site-directed mutagenesis. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[13]  F. Wurm,et al.  Biological properties of a CD4 immunoadhesin , 1990, Nature.

[14]  G. Winter,et al.  Construction of heterodimer tyrosyl-tRNA synthetase shows tRNATyr interacts with both subunits. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[15]  T. Kunkel.  Rapid and efficient site-specific mutagenesis without phenotypic selection. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[16]  D. Dowbenko,et al.  DNA sequence analysis of the type-common glycoprotein-D genes of herpes simplex virus types 1 and 2. , 1984, DNA.

[17]  R. Kelley,et al.  FAB Assembly and Enrichment in a Monovalent Phage Display System , 1991, Bio/Technology.

[18]  G. Winter,et al.  A model of synthetase/transfer RNA interaction as deduced by protein engineering , 1986, Nature.

[19]  L. Presta,et al.  Remodeling domain interfaces to enhance heterodimer formation , 1997, Protein science : a publication of the Protein Society.

[20]  P. Carter,et al.  Engineering subtilisin BPN′ for site‐specific proteolysis , 1989, Proteins.

[21]  K. J. Dorrington,et al.  Structure and function of immunoglobulin domains. III. Isolation and characterization of a fragment corresponding to the Cgamma2 homology region of human immunoglobin G1. , 1976, Journal of immunology.

[22]  H. M. Martinez,et al.  An RNA secondary structure workbench. , 1988, Nucleic acids research.

[23]  P. Carter,et al.  Toward the production of bispecific antibody fragments for clinical applications. , 1995, Journal of hematotherapy.

[24]  F. Sanger,et al.  DNA sequencing with chain-terminating inhibitors. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[25]  J. Wells,et al.  Hormone phage: An enrichment method for variant proteins with altered binding properties , 1990, Proteins.

[26]  H. K. Schachman,et al.  Regeneration of active enzyme by formation of hybrids from inactive derivatives: implications for active sites shared between polypeptide chains of aspartate transcarbamoylase. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[27]  J. Deisenhofer.  Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9- and 2.8-A resolution. , 1981, Biochemistry.

[28]  P. T. Jones,et al.  Isolation of high affinity human antibodies directly from large synthetic repertoires. , 1994, The EMBO journal.

[29]  E. Chen,et al.  Nucleotide sequence of the alkaline phosphatase gene of Escherichia coli. , 1986, Gene.

[30]  H. Heyneker,et al.  Nucleotide sequence of the gene for heat-stable enterotoxin II of Escherichia coli , 1983, Infection and immunity.

[31]  J. Vieira,et al.  Production of single-stranded plasmid DNA. , 1987, Methods in enzymology.

[32]  L. Presta,et al.  Development of a humanized disulfide-stabilized anti-p185HER2 Fv-beta-lactamase fusion protein for activation of a cephalosporin doxorubicin prodrug. , 1995, Cancer research.

[33]  L. Lasky,et al.  Protection from genital herpes simplex virus type 2 infection by vaccination with cloned type 1 glycoprotein D. , 1985, Science.

[34]  G. P. Smith,et al.  Antibody-selectable filamentous fd phage vectors: affinity purification of target genes. , 1988, Gene.

[35]  L. Presta,et al.  'Knobs-into-holes' engineering of antibody CH3 domains for heavy chain heterodimerization. , 1996, Protein engineering.

[36]  Leroy E. Hood,et al.  The nucleotide sequence of a human immunoglobulin C gamma1 gene , 1982, Nucleic Acids Res..

[37]  I. Kuntz,et al.  Engineering human immunodeficiency virus 1 protease heterodimers as macromolecular inhibitors of viral maturation. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[38]  P. Carter,et al.  Electrospray ionization mass spectrometry of recombinantly engineered antibody fragments. , 1994, Analytical chemistry.

[39]  S. Schreiber,et al.  Rational Design of Orthogonal Receptor - Ligand Combinations** , 1995 .

[40]  Leroy Hood,et al.  Nucleotide Sequence of a Human Immunoglobulin Cγ4 Gene , 1981 .

[41]  Thomas A. Kunkel,et al.  Rapid and efficient site-specific mutagenesis without phenotypic selection. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[42]  A. Fersht,et al.  Effects of engineering complementary charged residues into the hydrophobic subunit interface of tyrosyl-tRNA synthetase. Appendix: Kinetic analysis of dimeric enzymes that reversibly dissociate into inactive subunits. , 1987, Biochemistry.